Looking for breakthrough ideas for innovation challenges? Try Patsnap Eureka!

Temperature control gel rubber sustained-release injection containing resist metabolism series medicine

A technology for sustained-release injection and sustained-release gel injection, which is applied in the field of sustained-release gel preparation and sustained-release gel injection, and can solve problems such as tissue trauma, complex implantation process, and inability to effectively remove tumor cells.

Inactive Publication Date: 2008-05-14
SHANDONG LANJIN PHARMA +1
View PDF0 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Therefore, in most cases, the final sustained-release formulations are mostly solid shapes (eg, microspheres, tablets, or rods), which require a more complicated implantation process and are prone to tissue trauma and even tumor cell seeding or dissemination
In addition, organic solvents or high-heat processes often lead to the degradation and denaturation of many anti-cancer active ingredients, and solid implants cannot effectively cover the irregular tumor cavity after tumor resection. relapse

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Examples

Experimental program
Comparison scheme
Effect test

Embodiment 1

[0047] Put 4, 2, 1 and 0.5g of amphiphilic block copolymers (PLGA-PEG-PLGA) into four containers of A, B, C and D respectively, and then pour them into four containers of A, B, C and D respectively Add 6, 8, 9 and 9.5 milliliters of water for injection into the container to prepare 40%, 20%, 10% and 5% hydrogels.

[0048] The molecular weight of polyethylene glycol in the amphiphilic block copolymer is 800-1200, accounting for 20% of the weight of the amphiphilic block copolymer; in the glycolide-lactide copolymer, the ratio of glycolide and lactide The molar ratio is 6:1.

Embodiment 2

[0050] Measure the gelation temperature of four kinds of hydrogels in embodiment 1, the result shows that the gelation temperature of 40% and 20% hydrogel is respectively 28 ℃ (40%) and 35 ℃ (20%), and 10 The gelation temperatures of the % and 5% hydrogels were not determined at 10°C-38°C.

Embodiment 3

[0052] Put 4, 2, 1 and 0.5g of amphiphilic block copolymers (PLGA-PEG-PLGA) into four containers of A, B, C and D respectively, and then pour them into four containers of A, B, C and D respectively Add 6, 8, 9 and 9.5 milliliters of water for injection into the container to prepare 40%, 20%, 10% and 5% hydrogels.

[0053] The molecular weight of polyethylene glycol in the amphiphilic block copolymer is 1200-1600, accounting for 15% of the weight of the amphiphilic block copolymer; in the glycolide-lactide copolymer, the ratio of glycolide and lactide The molar ratio is 4:1.

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

No PUM Login to View More

Abstract

The invention discloses a temperature control and sustained release injection containing anti-metabolism medicine, which comprises anticancer effective dose anti-metabolism medicine, amphiphilic block copolymer and certain amount of medicine releasing regulation agent; wherein, the amphiphilic block copolymer comprises polyethylene glycol and polyester; the mixture of the amphiphilic block copolymer and the solvent without organic solvent has the gelation property of the temperature sensitive, is the fluidity liquid in the environment below the body temperature, can be automatically changed into the non-fluidity and biodegradation absorption water insoluble gel in the body of warm-blooded animal, the non-fluidity and biodegradation absorption water insoluble gel can release the anti-metabolism medicine slowly in the part of the tumor and maintain the effective medicine concentration of the effective medicine for a plurality of weeks or a plurality of months; the viscosity of the temperature control and sustained release injection is 10 cp to 3000 cp (5 DEG C to 30 DEG C), the temperature is 35 DEG C to 37 DEG C. The invention has the advantages of capability of injection inside or around the tumor or put inside the tumor cavity after the operation, obvious reduction of the systemic reaction of the medicine, and selective improvement of the therapeutic effect of the chemotherapy, the radiotherapy and other non-operation treatment method, and capability of curing the tumor in different stages.

Description

(1) Technical field [0001] The invention relates to a temperature-controlled gel sustained-release injection containing anti-metabolite drugs, and belongs to the technical field of pharmaceuticals. Specifically, the invention relates to a sustained-release gel preparation that can stably release anti-metabolite drugs locally into solid tumors. It is mainly a sustained-release gel injection. The sustained-release gel preparation is an aqueous solution at room temperature and can be administered in hot blood. It can become a semi-solid or solid gel in animals, so it can slowly release the contained antimetabolite drugs locally in the tumor, from days to weeks. (2) Background technology [0002] In recent years, conventional chemotherapy for tumors has made little progress. Local application of chemotherapy drugs, especially local sustained release, has shown good results and has become the current research direction and focus of solid tumor chemotherapy. However, current biod...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): A61K9/00A61K45/06A61K47/34A61P35/00
Inventor 孔庆忠王明华
Owner SHANDONG LANJIN PHARMA
Who we serve
  • R&D Engineer
  • R&D Manager
  • IP Professional
Why Patsnap Eureka
  • Industry Leading Data Capabilities
  • Powerful AI technology
  • Patent DNA Extraction
Social media
Patsnap Eureka Blog
Learn More
PatSnap group products